HOME >> MEDICINE >> NEWS
Second-generation antipsychotic medications appear to offer little advantage over older drugs

Among patients with schizophrenia whose medication is changed because of ineffectiveness or harmful side effects, second-generation antipsychotic drugs do not appear to offer significant benefits compared to first-generation antipsychotic drugs, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals. The findings run contrary to the widely held perception that second-generation antipsychotic agents are safer and more effective in treating patients with schizophrenia than the less-expensive first-generation class of medications.

For almost 50 years, antipsychotic medications have been the primary method of treating schizophrenia, a psychiatric disorder that causes a disconnect from reality and severe disturbances in thought, mood and behavior. Patients taking first-generation antipsychotics--so called because they were developed first--often relapse or develop severe side effects, including sedation (feeling tranquilized) and involuntary muscle movements, according to background information in the article. The development of second-generation antipsychotics was thought to be a major advance primarily because the drugs reduced such side effects. Claims that second-generation drugs are more effective than first-generation drugs have shifted treatment patterns away from first-generation medications, although research comparing the drug classes has had mixed results.

Peter B. Jones, M.D., Ph.D., University of Cambridge and Cambridgeshire and Peterborough Mental Health NHS Trust, Cambridge, England, and colleagues studied 227 individuals age 18 to 65 with schizophrenia. "The key question was whether the additional acquisition costs of second-generation antipsychotics over first-generation antipsychotics would be offset by improvements in health-related quality of life or savings in the use of other health and social care services in people with schizophrenia for whom a change in drug trea
'"/>

Contact: Peter B. Jones, M.D., Ph.D.
pbj21@cam.ac.uk
JAMA and Archives Journals
2-Oct-2006


Page: 1 2 3 4

Related medicine news :

1. USC-led study suggests little benefit from antipsychotics in Alzheimers
2. Most effective antipsychotic drug has serious health consequences
3. Number of children and teens treated with antipsychotics increases sharply
4. Atypical antipsychotic drugs for dementia may be associated with small increased risk of death
5. NIMH study finds antipsychotic Risperidone safe, effective as intermediate term treatment for autism
6. Metabolic side effects of antipsychotics are known, but rarely monitored
7. Different antipsychotic medications may have different effects on brain volume
8. Study shows new antipsychotic drug prevents brain loss in schizophrenia
9. Commonly used pain medications do not prevent Alzheimers disease
10. Standard long-acting insulin as good as newer medications
11. MS patients not receiving medications to slow disease progression, research shows

Post Your Comments:
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
(Date:3/5/2015)... March 05, 2015 HomeCEUConnection.com ... March with extra savings on their nutrition ... of health and nutrition, HomeCEUConnection.com is offering ... the promo code, NUTRITION2015 . , ... , HomeCEUConnection.com provides high-quality continuing education ...
(Date:3/5/2015)... On March 2, 2015, NBC News posted ... Rise, Plastic Surgeons Say,” that comments on the 2014 ... Plastic Surgery and the American Society of ... doubling of surgical butt augmentations performed in 2014. According ... this increase can be attributed to the social impact ...
(Date:3/5/2015)... In honor of National Drug Facts Week, ... and alcohol abuse in schools and communities across America, ... information on some of the dangers and statistics involved ... Institute on Drug Abuse, this annual promotion of the ... illusions that teens and young adults get from television, ...
(Date:3/5/2015)... MS (PRWEB) March 05, 2015 At ... Basics and Beyond,” leaders in addiction treatment met today ... updates in best clinical practices. Among the numerous respected ... , who will address the role that pain medications ... and new evidence-based treatment options. , "It is hard ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3
(Date:3/5/2015)... -- AMRI (NASDAQ: AMRI ) announced today that ... of VP of International Sales, effective immediately. He reports ... Global Sales and Marketing. In this ... in an effort to increase worldwide customer value and ... will drive strategy for sales and marketing efforts across ...
(Date:3/5/2015)... , March 5, 2015 - ... agency ( http://www.epa.eu ) - Hitachi ... della nuova generazione di OASIS* all,ECR 2015. Si tratta ... alto campo da 1.2 T che migliora la capacità ... traguardo nell,attenzione al comfort del paziente. Le nuove funzionalità ...
(Date:3/5/2015)... March 5, 2015 Soligenix, Inc. (OTCQB: SNGX) ... committed to developing products that address unmet medical needs ... today that its President and Chief Executive Officer, ... presentation at the 27 th Annual ROTH Conference ... Tuesday, March 10, 2015 at 1:00 PM Pacific Daylight ...
Breaking Medicine Technology:AMRI Hires VP of International Sales 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
Cached News: